Insecticides India reported a steady Q4. In an interview to CNBC-TV18, Sandeep Aggarwal, CFO of Insecticides India spoke about the results and his outlook for the company.
Rajesh Aggarwal, Managing Director and CEO, Insecticides is confident of good growth continuing in the second half as well and expects the FY17 topline to be above Rs 1100 crore.
Rajesh Aggarwal, Managing Director and Chief Executive of Insecticides India, expects that beginning June the company will see recovery in its business.
While the company's margins dipped owing to discounts it offered to create demand, Insecticides still expects to benefit from economies of scale, says Rajesh Aggarwal, MD & CEO, Insecticides.
Revenue growth in the second half of FY16 is likely to be in the 10-15 percent range, says Sandeep Aggarwal, CFO, Insecticides India. He also spoke about his company's performance in the second quarter.
Rajesh Aggarwal, MD and CEO of Insecticides says shortage of rainfalls in Q1 caused slowing of industrial growth.
In an interview with CNBC-TV18, Sandeep Aggarwal, CFO, Insecticides India said that sales and business days will both be impacted with deficient rainfall in July and August.
Rajesh Aggarwal, managing director and chief executive officer, Insecticides India doesn't see a bleak picture for the upcoming quarters as the untimely rainfall will be good for the kharif crops, he explains.
Speaking to CNBC-TV18 post Q3 earnings, Rajesh Aggarwal, MD and CEO, Insecticides India said the Dahej plant which was shut during Diwali week is operational now. The small cap company expects to see a recovery in Q4 FY15.
SBI Capital Markets is bullish on Insecticides India stock and recommends buying with a target price of Rs 1,031 per share. The stock is currently trading around Rs 870 per share.
Insecticides India plans to make one R&D centre to establish a good laboratory practice (GLP) laboratory with approximately Rs 20 crore of maintenance capex for two-three years.
Insecticides India recorded a 66 percent rise in second quarter net profit at Rs 22.9 crore versus Rs 13.8 crore, year-on-year. While net sales were up by 18 percent at Rs 402 crore versus Rs 340 crore, Y-o-Y.
Sandeep Aggarwal, CFO of Insecticides India says the capacity utilisation from the Dahej unit would be around 75 percent and expect the unit to add to the financials of the company in a big way.
Rajesh Aggarwal, MD & CEO, Insecticides India expects utilisation at Dahej facility to go up to 75 percent in the next fiscal from current 50 percent.
In an interview to CNBC-TV18 Rajesh Aggarwal, chief managing director, Insecticides India hinted at an average 5% price hike.
In an interview with CNBC-TV18, Rajesh Agarwal, CMD of Insecticides India attributes its growth to the launch of new brands and collaborations with American and Japanese companies.
Sandeep Agarwal, chief financial officer of Insecticides India speaking to CNBC-TV18 about debt concerns said, the company is looking to raise around Rs60- Rs70 crore through private equity (PE) route.
Insecticides India is looking to enter the export market. In an interview to CNBC-TV18, Sandeep Agarwal, chief financial officer of Insecticides India said, within two-three months, the company will be exporting to South East Asian counties.
In an interview to CNBC-TV18, Sandeep Agarwal, CFO of Insecticides says the company is all set to extend itself with an infusion of Rs 60-70 crore, in next two years. "We are planning for expansion in all our existing plant and for the setup of a new plant at Bhiwadi, Rajasthan," says Agarwal.
In an exclusive interview with CNBC-TV18, Rajesh Agarwal, chairman and managing director of Insecticides India says that in the first quarter, the company has seen 10-15% increase in the market price.
Rajesh Agarwal, MD of Insecticides India in an interview with CNBC-TV18 said, "We are targeting an increase of about 40% in our topline this year. We see our sales going to Rs 700 crore in the year 2012."
In an interview with CNBC-TV18, Rajesh Agarwal, CMD, Insecticides (India) says, there can be an opportunity for a direct investment in our company.
In an exclusive interview with CNBC-TV18’s Ekta Batra and Reema Tendulkar, Agarwal says, “We are targeting that this brand should give us sales growth of about 10%. Monocil will become our fourth key brand and is going to give us a share of Rs 40 crore to Rs 50 crore.”
Rajesh Agarwal, chairman and managing director of Insecticides India, said," We should successfully able to close the deal by end this week. The company expects the new brand to contribute 10% of its topline, he added.